Development and challenges of mRNA-based therapeutics
Chinese Journal of New Drugs
; 30(22):2029-2033, 2021.
Article
in Chinese
| Scopus | ID: covidwho-1589974
ABSTRACT
mRNA-based drug has already become a focus as a potential new type of drug in recent years. With the rapidly evolving technologies, mRNA has been widely applied in various areas of clinical research, such as immune disease, oncological disease, infectious disease, and congenital metabolic disorder. Since the outbreak of COVID-19, there has been a great leap in mRNA vaccine development, forecasting that much more mRNA medicines will enter the market in the near future. In order to meet industrial requirements, this article provides an overview of the product profiles of mRNA-based drugs and their industrial landscape, and further discusses the key considerations in the manufacturing of such medicines. © 2021, Chinese Journal of New Drugs Co. Ltd. All right reserved.
Search on Google
Collection:
Databases of international organizations
Database:
Scopus
Language:
Chinese
Journal:
Chinese Journal of New Drugs
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS